Back to 
TUDOR INVESTMENT CORP ET AL
TUDOR INVESTMENT CORP ET AL
ARWR
Showing 4 of 19 quarters
Position history for TUDOR INVESTMENT CORP ET AL's holdings in ARROWHEAD PHARMACEUTICALS IN
No. Tudor Investment exited its ARWR (Arrowhead Pharmaceuticals in) position in Q2 2025. Its Q1 2025 13F listed 65,708 shares worth $837,120. Tudor Investment first reported ARWR in Q4 2019 and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$1.2M
Total Shares Change
-62,424
Quarter-by-Quarter History